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ABSTRACT
Objective: To ascertain inƀ ammatory response through interleu-
kin 1ȕ presence and identify pathogenic microorganisms as pos-
sible immunological and microbiological markers in diagnosis and 
treatment non-surgical periodontal in patients with gingivitis and 
moderate chronic periodontitis in a sample of Mexican population. 
Material and methods: In the present prospective cohort study, 
18 patients with signs of gingivitis and 17 patients with moderate 
chronic periodontitis were selected. Samples of subgingival bioſ lm 
and of crevicular gingival ƀ uid were collected. Interleukin 1ȕ was 
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RESUMEN
Objetivo: Conocer la respuesta inƀ amatoria a través de la presencia 
de interleucina 1ȕ e identiſ car microorganismos patógenos como 
posibles marcadores inmunológicos y microbiológicos en el 
diagnóstico y tratamiento periodontal no quirúrgico en sujetos con 
gingivitis y periodontitis crónica moderada en población mexicana. 
Material y métodos: En este estudio prospectivo de cohortes, se 
seleccionaron 18 pacientes con signos clínicos de gingivitis y 17 
pacientes con periodontitis crónica moderada, se recolectaron las 
muestras de biopelícula subgingival y de ƀ uido gingival crevicular. 
Non surgical periodontal treatment in patients with gingivitis 
and moderate periodontitis. 
Biochemical and microbiological response
Tratamiento periodontal no quirúrgico en pacientes con gingivitis y periodontitis 
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Abbreviations:
Units
  Base 10 logarithm  =  log
  Microliters  =  ȝL
  Milliliters  =  mL
  Pictograms  =  pg
  Percentage  =  %
  Revolutions per minute  =  rpm
  Seconds  =  sec
Acronyms
 APC  =  Antigen presenting cells.
 BANA  =  NĮ-Benzol-DL-Arginineȕ-Naphtilamide.
 BMPs  =  Bone morphogenic proteins.
 Ep  =  Gingival epitelial cells.
 CGF  =  Crevicular gingival ƀ uid.
 IFNȖ  =  Gamma interferon.
 IL  =  Interleukin.
 IL-1Į  =  Interleukin 1 alpha.
 IL-1ȕ  =  Interleukin 1 beta.
 IL-1AcP  =  Accessory protein of receptor to IL-1.
 IL-RĮ  =  Antagonist receptor.
 IL-IRI  =  Type I receptor to IL-1.
 IL-RII  =  Type II receptor to interleukin 1.
 iNOS  =  Nitric oxide oxidase.
 LB  =  B lymphocyte.
 LT  =  T lymphocyte.
 LPS  =  Bacterial lipopolysaccharide.
 MCH  =  Main histocompatibility complex.
 MMPs  =  Matrix metalloproteinases.
 NK  =  Natural leukocytes of «natural killers».
 PAMPs  =  Pathogen-associated molecular patterns.
 PGE2  =  Prostaglandin E2.
 PGI2  = Prostaglandin I2.
 PMN  =  Polymorphonuclear leukocytes. 
 RSP  = Root scaling and planing.
 TCR  =  T cell receptors.
 TH0  =  Cooperative T lymphocyte.
 TH1  =  Cooperative T lymphocyte 1.
 TH2  =  Cooperative T lymphocyte 2.
 TIMPs  =  Inhibitor factors of matrix metalloproteinases.
 TNFĮ  =  Alpha tumoral necrosis factor.
 TNFȕ  =  Beta tumoral necrosis factor.
 CFU  =  Colony forming units.
 VCAM  =  Vascular cell adhesive molecule.
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INTRODUCTION
Within the scope of periodontal disease two 
entities are distinctive, and they possess clearly 
defined phenotypes: gingivitis (G) and periodontitis 
(P). These conditions can be clinically observed 
through chronic inflammatory processes, although 
in one case (periodontitis) this process evolves and 
destroys the periodontal attachment apparatus, and 
in the other case (gingivitis) the inƀ ammatory process 
is maintained with no evolution towards destruction.1-6 
This inf lammatory and immune response is 
determined by the presence of periodontal pathogens 
which are Gram negative anaerobic bacteria involved 
in the subgingival bioſ lm1,7-11 such as Porphyromonas 
gingivalis, Aggregatibacter actinomycetemcomitans 
(Ac), Tannerella forsythia (Tf), Prevotella intermedia 
(Pi), Fusobacterium nucleatum (Fn), Parvimonas 
micra  (Pm),  Campylobacter rectus (Cr)  and 
Actinomyces ssp.11-16 as well by biological modifying 
factors such as: systemic factors, genetic factors17,18 
and behavioral factors such as oral hygiene, smoking 
habits and stress.19 In periodontal attachment tissue, 
inƀ ammatory response comes forth with great amounts 
of neutrophil polymorphonuclear leukocytes (PMNs) 
and macrophages with phagocytosis and destructive 
functions in the sites of bacterial interaction with tissue 
surface, inciting the presence of inƀ ammatory inſ ltrate, 
the activation of the immune system, complement 
cascade and the cytokine production system.10,20,21 
Most of the substances released by inflammatory 
and immune cells concentrate in an exudate, 
characteristic of inflammatory processes observed 
in G and moderate chronic periodontitis (MCP). This 
substance (fluid) is called crevicular gingival fluid 
(CGF). In this ƀ uid it is possible to identify the following 
pro-inƀ ammatory cytokines: 1-beta interleukin (IL-1ȕ) 
as well as alpha tumor necrosis factor (TNF-Į). Both 
cytokines are mediators of the inƀ ammatory process 
because they modulate the extracellular component 
of bone and connective tissue. In periodontal disease 
they show high CGF levels, therefore they can have 
diagnostic interest in G and MCG, since they can be 
associated to the active phase of these conditions.22-25
The aim of the present study was to contribute to the 
knowledge of microbial ƀ ora in this sample of Mexican 
population and assess links between microbial ƀ ora and 
immunological response in G and its progression to MCP. 
A prospective cohorts study was conducted to endeavor 
to find differential aspects with respect to etiological 
factors and host response. For this purpose quantiſ cation 
of IL-1ȕ in the CGF was used as immunological marker 
and to examine the effect of NSPT at the pre-treatment, 
post-treatment and maintenance phases.
MATERIAL AND METHODS
Patient selection
18 patients were selected with clinical and 
radiographic diagnoses of G (evidence of gingival 
inƀ ammation, volume increase of the gums, redness 
and haemorrhage when probing, without loss of 
epithelial attachment) and 17 patients with MCP (loss 
of insertion in three or more sites in all quadrants, 
with pocket depth of 5-7 mm in three or more sites, 
radiographic evidence of bone loss at a half of the root 
length in three or more sites of all quadrants, bleeding 
quantiſ ed during the pre-treatment, post-treatment and maintenan-
ce phases of the non- surgical periodontal treatment. Continuous 
variables were analyzed with the Student test, as well as categorical 
variables which were analyzed with the Turkey-Kramer test. For in-
dependent groups the Pearson test was used. Results: Microbio-
logical response variables showed that Porphyromonas gingivalis 
Prevotella intermedia, Fusobacterium nucleatum, Aggregatibacter 
actinomycetemcomitans significantly decreased in subjects with 
gingivitis, Porphyromonas gingivalis, Tannerella forsythia, Fuso-
bacterium nucleatum, Aggregatibacter actinomycetemcomitans and 
Actinomyces ssp. decreased in cases. Biochemical response varia-
bles showed signiſ cant decrease in IL-1ȕ concentration and total 
count in individuals with moderate chronic periodontitis in treatment 
maintenance phase. The same result applied to clinical response 
variables. Conclusions: There is a decrease in Interleukine 1ȕ le-
vels with decrease in microƀ ora. Interleukin 1ȕ are sensitive markers 
for diagnosis of periodontal disease and assessment of its severity.
Se cuantiſ có la interleucina 1ȕ durante las fases pretratamiento, 
postratamiento y de mantenimiento del tratamiento periodontal no 
quirúrgico. Resultados: Las variables de respuesta microbiológica 
mostraron que Porphyromonas gingivalis, Prevotella intermedia, 
Fusobacterium nucleatum, Aggregatibacter actinomycetemcomitans 
disminuyeron significativamente en individuos con gingivitis. 
Así como Porphyromonas gingivalis, Tannerella forsythia, 
Fusobacterium nucleatum, Aggregatibacter actinomycetemcomitans 
y Actinomyces sp. en periodontitis crónica moderada. Las variables 
de respuesta bioquímica mostraron una disminución signiſ cativa en 
la concentración y cuenta total de interleucina 1ȕ en los individuos 
con periodontitis crónica moderada en la fase de mantenimiento 
del tratamiento así como de las variables de respuesta clínica. 
Conclusión: Hay reducción de los niveles de interleucina 1ȕ con 
la disminución de la microflora. Los niveles de interleucina 1ȕ 
son marcadores sensibles para el diagnóstico y severidad de la 
enfermedad periodontal.
Key words: Non surgical periodontal treatment, Mexican population, gingivitis, moderate periodontitis.
Palabras clave: Tratamiento periodontal no quirúrgico, población mexicana, gingivitis, periodontitis crónica moderada.
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was immediately placed in a sterile Eppendorf tube 
at -70o C until analyzed. The volume of the ƀ uid was 
determined using a Periotron® 8000 and a previously 
constructed calibration curve.
Microbiological sample processing
A vortex-mixed sub-gingival plaque was dispersed for 
30 seconds. Dilution was performed from the initial sample. 
Four successive dilutions were carried out at the tenth part 
with phosphate buffering solution (PBS) at neutral pH. 0.1/
mL of the diluted sample was inoculated over the plaques 
containing agar-blood (non-selective) media; incubation 
was performed at 37o C. P. gingivalis, P. intermedia, 
P. micra, F. nucleatum, T. forsythia, C. rectus and 
Actinomyces sp. were grown on fastidious anaerobe agar, 
and harvested after seven days. A ſ fteen-day period was 
observed for slow growing species soy agar vancomycin 
bacitracin (TSBV) (selective media). Incubation was 
carried out at 37o C. A. actinomycetemcomitans was 
grown in 5% carbon dioxide atmosphere, and harvested 
after ſ ve days (Herrera GD, Stijine-van NA, Bosch TCJ, 
Dentokom MEC, Boersme H, Zeiler G, Winkelhoff AJ. 
[1998]). Microbiological Procedures with Periodontal 
Anaerobic Bacteriae. Working protocol, Microbiology 
Laboratory, School of Dentistry, UCM, Spain, UCM, 
Spain.28 Colony morphology was carried out, as well 
as optical microscopy, Gram stain and BIG, APY, 
ZYM biochemical tests for bacterial identiſ cation were 
equally performed.30-32
Analysis of GCF samples
GCF samples were eluted into incubation buffer 
(PBS) at 7.4 pH on a rotary mixer. Paper strips were 
discarded. 50 zL of GCF aliquot was used by IL-1ȕ, 
analysis was measured using the enzyme-linked 
immune-sorbent assay (ELISA) by according to the 
method recommended by the manufacturer. Quadratic 
regression was calculated to obtain formulae and 
graphs which translate capacitance units of digital 
readings of each paper strip, from the Periotron® 8000 
measuring device to indicate zL volume. (Norma Oſ cial 
Mexicana-Ensayos Clínicos NOM-013-SSA2-1994 
y el Comité de Bioética de la UAM Xochimilco.) The 
guides ethical to the cohort study was the Mexican 
Ofſ cial Statement of Clinical Assay and the Bioethic 
Comite UAM Xochimilco.
STATISTICAL ANALYSIS OF DATA
To perform analysis for differences to be found 
among groups of the G group when compared to the 
when probing in three or more sites of each quadrant). 
These patients attended the San Lorenzo and Tepepan 
Stomatological Clinics, attached to the Metropolitan 
Autonomous University, campus Xochimilco, in 
Mexico City. All patients granted informed consent, 
had not received previous periodontal treatment, and 
participated of their own volition in the study. Mean 
time between sampling was 12 months.
Study outline
After an initial screening visit for recruitment, during 
the first eight weeks, baseline measurements were 
recorded and samples taken. Subsequently, hygiene 
instruction was undertaken and NSPT (scaling and 
root planing) (SRP) was performed. Patients were re-
assessed two months after the SRP procedure. On the 
following visit, post treatment clinical measurements 
were recorded, and microbiological and immunological 
samples were taken from the same sites. Patients were 
then reassessed six months later, this was considered 
the maintenance phase visit. At this point, clinical 
measurements were recorded and microbiological and 
immunological samples were taken from the same sites.
Clinical measurements and sampling
Four sites were selected in each G and MCP 
patient, whenever possible, one site was selected in 
each quadrant. The following tests were conducted 
and recorded: Quigley and Hein plaque index (PI) 
modified by Turkey. Löe and Silness gingival index 
(GI), probing of sulcus depth (PSD), probing of pocket 
depth (PPD) and clinical attachment loss (CAL).26,27 
Each tooth was PI determined, GI assessed; pocket 
depth and attachment loss were measured at each 
site using the f-6 pgf Hu-Friedy probe. After the clinical 
measurements were recorded, a supragingival plaque 
sample was obtained from each site using sterile 
curettes. Each tooth was isolated with sterile gauze 
and then air-dried. A sub-gingival plaque sample was 
obtained with two paper points, introduced for 10 
seconds each, following the Mombelli technique.
Each sample was immediately placed in a sterile 
Eppendorf tube containing reduced transport fluid 
(RTF) (Herrera GD, Stijine-van NA, Bosch TCJ, 
Dentokom MEC, Boersme H, Zeiler G, Winkelhoff AJ. 
[1998]). Microbiological Procedures with Periodontal 
Anaerobic Bacteriae. Working protocol, Microbiology 
Laboratory, School of Dentistry, UCM, Spain.28
And was processed within the two hours after 
recollection. Lastly, GCF was collected using paper 
strips, in place for 10 seconds each.22,29,30 Each sample 
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MCP group for continuous variables, the t Student test 
was calculated. For categorical variables the Tukey-
Kramer test was used with a p < 0.0001 between pre-
treatment, post-treatment and maintenance phase of 
each studied condition. To analyze differences among 
groups in independent G groups versus MCP, the 
Pearson test was applied with a p Į 0.05 for all three 
phases.
RESULTS
Variable clinical responses
The clinical parameters in the pre-treatment, post-
treatment and maintenance phases, in the SRP in G 
and MCP is shown in tables I and II. NSPT resulted in 
signiſ cant reduction in PSD in the G group and PPD 
in the MCP group with a p < 0.0001, difference found 
among the groups was p Į 0.03 and CAL in MCP 
group p < 0.0001. The PI in G and MCP group with 
p < 0.0001 and inter-group comparison was p Į 0.03. 
Gingival Index in group G and MCP with a p < 0.0001 
with inter-group difference of p Į 0.03.
Microbiological response variables
In both groups it was observed that all assessed 
species presented a decrease in the total bacterial 
count (UFC/mL x 103). A statistically significant 
difference was observed between among treatment 
phases with a p < 0.0001, with inter-group difference 
of p Į 0.02 (Figure 1 and Table III).
The behaviour of studied species Porphyromonas 
g ing iva l i s  (Pg ) ,  Tannere l l a  fo rsy th ia  (T f ) , 
Fusobacterium nucleatum (Fn), shows a bacterial 
count (UFC/mL x 103) greater in subjects in initial 
phase periodontitis Prevotella intermedia (Pi), and 
Campylobacter rectus (Cr), presented a greater 
bacterial count in subjects with gingivitis at the same 
phase.
Porphyromonas gingivalis (Pg), Tannerella forsythia 
(Tf), Fusobacterium nucleatum (Fn), Aggregatibacter 
actinomycetemcomitans (Aa) and Actinomyces sp. 
(A.sp) manifest a statistically significant reductions 
after treatment, in maintenance phase a lower bacterial 
count in MCP patients, Prevotella intermedia (Pi), 
Fusobacterium nucleatum (Fn) and Aggregatibacter 
Table I. Clinical variables in gingivitis.
Clinical parameter
p < Pre-treatment Post-treatment Maintenance
PI 55.7 (± 10.4) 33.5 (± 15.0) 13.7 (± 4.9)
0.0001
GI 1.8 (± 0.2) 1.2 (± 0.5) 0.4 (± 0.1)
0.0001
PSD 2.1 (± 0.5) 1.7 (± 0.4) 1.6 (± 0.3)
0.0024
Clinical variables after non surgical periodontal treatment in G. For clinical variables the following were considered: plaque index (PI), gingival 
index (GI), probing sulcus depth (PSD) in the three phases of the non surgical treatment in subjects with gingivitis.
Table II. Clinical variables in moderate chronic periodontitis.
Clinical parameter
p < Pre-treatment Post-treatment Maintenance
PI 63.4 (± 20.0) 29.2 (±  19.1) 18.4 (± 9.5)
0.0001
GI 1.8 (± 0.4) 1.1 (± 0.2) 0.6 (± 0.3)
0.0001
PPD 4.6 (± 0.7) 2.6 (± 0.6) 2.5 (± 0.9)
0.0001
CAL 2.6 (± 0.4) 1.7 (± 0.3) 1.7 (± 0.2)
0.0001
Clinical variables after non surgical periodontal treatment in MCP the following were considered as clinical variables: plaque index (PI), gingival 
index (GI), probing pocket depth (PPD), clinical attachment level (CAL) in the three phases of non surgical treatment in subjects with moderate 
chronic periodontitis.
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Ac. sp
A. a
C. rectus
P. micra
F. nucleatum
T. forsythia
P. intermedia
P. gingivalis
Initial bacterial count in gingivitis and moderate chronic periodontotis patients
0             200           400           600            800          1000         1200
UFC/mL(×103)
Periodontitis
Gingivitis Figure 1. 
Mean total bacterial count of UFC/
mL of eight bacterial species in 
samples taken from 18 gingivitis 
patients and 17 moderate chronic 
periodontitis patients. Attention 
must be brought to the fact that 
the highest bacterial count in 
gingivitis was P. intermedia, C. 
rectus and Actinomyces sp. in 
periodontitis it was P. gingivalis, 
T. forsythia and F. nucleatum.
Pre-treatment-T
Maintenance
Ac. sp
A. a
C. rectus
P. micra
F. nucleatum
T. forsythia
P. intermedia
P. gingivalis
Bacterial countin gingivitis patient
0         100       200       300       400       500       600      700       800
UFC/mL(×103)
Figure 2. 
Mean total bacterial count of UFC/
mL of eight bacterial species in 
samples taken from 18 gingivitis 
subjects. Samples were obtained 
at initial and maintenance phases 
of the periodontal treatment. 
Attention must be brought to 
the fact that the higher bacterial 
count in gingivitis corresponded 
to P. gingivalis, C. rectus, and 
Act inomyces sp.  during the 
maintenance phase.
e156 Macín-Cabrera S et al. Non surgical periodontal treatment. Biochemical and microbiological response
www.medigraphic.org.mx
actinomycetemcomitans (Aa) manifested a lower 
count in gingivitis patients, twelve months after 
treatment, during the maintenance phase.
After NSPT gingivitis patients showed positive 
Porphyromonas gingivalis without manifestation of 
significant decrease and nevertheless revealing a 
49% increase in the UFC, as shown in ſ gures 1 to 3.
Immunological variable responses
Results of CGF volume in microliters (zL) showed 
that it was more abundant in subjects with MCP when 
compared to G patients (Table IV). Values obtained 
from the pre-treatment phase up to the maintenance 
phase revealed that CGF volumes experienced a 
statistically signiſ cant reduction with a p < 0.0001 in G 
and p < 0.0005 in MCP. Table IV shows quantiſ cation 
of concentration in pictograms per microliter (pg/
zL) of 1ȕ interleukin where, a greater reduction can 
be seen between initial and maintenance phase in 
MCP patient group, with a p = 0.000 statistically 
meaningful. This situation did not occur in the G 
patient group who presented a p > 0.17. IL-1ȕ total 
picogram quantification for each group of disease 
measured per treatment phase showed that G group 
patients showed p > 0.06 and MCP group patients p 
< 0.00 it was statistically signiſ cant only for the MCP 
group.
DISCUSSION
Response to treatment
In the present study, disease of moderate chronic 
periodontitis (MCP) patients was controlled with 
non surgical periodontal treatment (NSPT). There 
was an unequivocal relationship of NSPT treated 
cases with the reduction of all clinical parameters. 
Probing depth showed average reduction of 2.02 
mm. This is higher than what is normally reported 
in scientific literature.33,34 In average, the amount of 
gained attachment was higher to that presented in 
previous reports: amount gained was in average 0.9 
mm. In MCP cases, twelve months after treatment 
there was a decrease in the amount of periodontal 
pathogenic bacteria P. gingivalis, T. forsythia, 
 Table III. Microbiological data for each species.
G/MCP Pre-treatment Post-treatment Maintenance p <
Pg 283.3 ± 266.2 611.0 ± 119.5 555.5 ± 175.4 0.00
664.7 ± 757.4 223.5 ± 420.6 141.1 ± 234.6 0.01
pĮ 0.54 0.10 0.35
Pi 500.0 ± 104.3 111.1 ± 0.3 222.2 ± 548.3 0.24
174.1 ± 262.4 447.0 ± 100.1 235.2 ± 0.9 28.5
pĮ 0.99 0.06 0.89
Tf 111.1 ± 171.1 0.0 ± 0.0 111.1 ± 471.4 0.00
705.8 ± 168.8 294.1 ± 985.1 0.00 ± 0.0 0.19
pĮ 0.01 0.00 0.00
Fn 350.0 ± 297.3 150.0 ± 194.8 100.6 ± 190.8 0.00
982.5 ± 642.9 194.1 ± 213.1 211.6 ± 161.6 0.00
pĮ 0.34 0.22 0.01
Pm 183.3 ± 212.3 138.8 ± 232.8 216.6 ± 277.6 0.62
217.4 ± 283.6 223.2 ± 167.1 252.4 ± 267.0 0.90
pĮ 0.07 0.79 0.98
Cr 555.5 ± 783.8 333.3 ± 766.9 722.2 ± 184.8 0.64
264.7 ± 492.4 105.9 ± 248.7 824.0 ± 255.5 0.11
pĮ 0.24 0.76 0.67
Aa 183.3 ± 200.3 388.8 ± 103.9 0.00 ± 0.0 0.00
147.5 ± 200.6 764.7 ± 139.2 58.8 ± 24.2 0.02
pĮ 0.54 0.09 0.00
Ac. sp. 444.4 ± 222.7 133.3 ± 244.4 600.0 ± 108.9 0.39
423.2 ± 347.6 647.0 ± 122.7 105.8 ± 210.6 0.00
pĮ 0.77 0.00 0.01
Microbiological data consist on UFC/mL (x 103) expression for each species obtained during the three phases of the non-surgical periodontal 
treatment in 18 subjects with gingivitis and 17 subjects with moderate chronic periodontitis, P. gingivalis (Pg), P. intermedia (Pi), T. forsythia (Tf), 
F. nucleatum (Fn), Parvimonas micra (Pm), A. actinomycetemcomitans (Aa) y Actinomyces sp. (Ac. sp.).
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Table IV. Crevicular gingival ƀ uid and IL-1ȕ concentration and total picograms.
G/MCP Pre-treatment Post-treatment Maintenance p <
CGF 0.53 ± 0.22 0.33 ± 0.16 0.31 ± 0.11 0.0001
0.81 ± 0.33 0.52 ± 0.24 0.36 ± 0.16 0.0005
pĮ 0.26 0.24 0.28
Conc. IL-1ȕ (pg/ȝL) 0.224 ± 0.36 0.177 ± 0.21 0.073 ± 0.08 > 0.17
0.256 ± 0.15 0.212 ± 0.14 0.084 ± 0.09 0.00
pĮ 0.24 0.24 0.24
Total picograms 0.112 ± 0.01 0.053 ± 0.06 0.033 ± 0.03 > 0.06
0.247 ± 0.18 0.180 ± 0.17 0.034 ± 0.05 0.0005
pĮ 0.24 0.24 0.24
Crevicular gingival ƀ uid mean volume (CGF) comparison, (pg/ȝL) concentration and IL-1ȕ total picograms in CGF samples of subjects with G 
and MCP during the three phases of non surgical procedure. pĮ = 0.05.
Figure 3. 
Mean total bacterial count of 
UFC/mL on eight  bacter ia l 
samples taken from 17 moderate 
chronic periodontitis subjects. 
Samples were obtained at initial 
and maintenance phase of the 
periodontal treatment. Attention 
must be brought to the fact that 
the higher bacterial count in 
moderate chronic periodontitis 
corresponded to P. intermedia 
and  C .  r ec tus  du r i ng  t he 
maintenance phase.
Ac. sp
A. a
C. rectus
P. micra
F. nucleatum
T. forsythia
P. intermedia
P. gingivalis
Bacterial counting gingivitis patient
0              200             400             600             800           1000           1200 
UFC/mL(×103)
F. nucleatum, A. actinomycetemcomitans, and 
Actinomyces sp. This is in concordance with other 
reports.35,36 In this study, NSPT decreased IL-1ȕ 
concentration in CGF this is in direct relationship 
with clinical parameters where GI of 1.8 ± 0.5 was 
reduced to 0.6 ± 0.3 (p < 0.0001). These facts 
are in agreement with research conducted by 
Engebretson,23 and Lein-Tuan.37
Etiologic factors
In the present study, differences found among 
sub-gingival biofilm samples of Mexican subjects 
with gingivitis (G) and moderate chronic periodontitis 
(MCP) conſ rm, in general terms, previous descriptions 
manifested in scientific literature. The periodontal 
pathogenic microbiota showed quantitative differences 
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between both study groups. This is in concordance 
with studies conducted by Sanz,11 and specifically 
in Mexican population and this coincides with the 
frequency of P. gingivalis and F. nucleatum.14 This 
was not the case for the frequency of the other six 
studied species. The differing results may reflect 
the microbiological test used or differences in the 
groups of examined patients. Non surgical periodontal 
treatment (NSPT) was effective for reduction of the 
eight periodontal pathogenic bacteria in MCP, with a 
statistically signiſ cant difference, which is associated 
to the reduction of clinical parameters when compared 
with studies conducted by Rawlinson,38 Haffajee,33 
Mombelli.39 This reduction was consolidated in the 
maintenance phase of individuals with MCP; and was 
due to the control of the subgingival bio-film. In the 
group of G individuals, after NSPT, P. gingivalis showed 
an increase in bacterial count in the maintenance 
phase when compared to the pre-treatment phase. 
This can be related to the poor response to treatment 
of patients with sites that were positive to these 
bacteria, as well as to the speciſ c virulence factors of 
these periodontal pathogenic bacteria. Nevertheless, 
we did not ſ nd studies in agreement with our ſ ndings. 
Notwithstanding, there were studies where P. 
gingivalis induce inƀ ammatory mediators in blood.40 
In MCP, NSPT was associated to the decrease of 
IL-1b levels, as well as reduction of P gingivalis, T. 
forsythia, F. nucleatum, A. actinomycetemcomitans, 
Actinomyces sp. at twelve months, in the maintenance 
phase. This is statistically signiſ cant when compared 
with studies conducted by Mogi.41 In these studies, 
the prevalence of periodontal pathogenic bacteria is 
associated to the concentration of IL-1ȕ, due to the 
fact that CGF volume was correlated to the distinctive 
process of periodontitis.42
Host factors
This study shows that in the concentration of IL-
1ȕ in GCF pg/zL as well as in total pg in G there is 
no statistically significant difference among NSPT 
phases when compared with MCP condition, where 
statistically significant differences among treatment 
phases were manifested. For the aforementioned 
reasons, this research supports the fact that 
periodontal pathogenic bacteria are ubiquitous in 
the oral cavity, and in many individual infections and 
diseases are limited or absent. We can infer that from 
this fact derives the importance of the host response 
as susceptibility potential determinant, as previously.43 
It can equally be inferred that the balance or 
imbalance between bio-ſ lm and inƀ ammatory process 
is the determinant factor for the severity of the lesion 
in MCP lesions. This is due to the fact that enzyme 
levels, antibodies, complement factors, interleukines, 
and other antibacterial factors contained in the CGF 
augment in quantity. This increase is an indication of 
the severity of periodontal-gingival inƀ ammation. Its 
sulcus progressing to pocket depth is an unequivocal 
sign of these conditions.44 It is also in concordance with 
clinical and experimental evidence which support the 
idea that MCP is not a conventional bacterial infection, 
it rather is an inƀ ammatory condition triggered by the 
hosts immune response towards the poly-microbial 
infection of the associated bio-ſ lm.45 Our ſ ndings in 
this research show that quantity or concentration of IL-
1ȕ in the CGF are useful markers for the association of 
severity and progression in gingivitis and periodontitis 
cases. This is in agreement with researchers such 
as Eley,22 Goutodi,46 Orozco47 Castrillón25 since, 
determining CGF volume and proinflammatory 
cytokines is useful to predict and associate progressive 
attachment loss. This is the case of IL-1ȕ, which 
is liberated by macrophages, polymorphonuclear 
leukocytes, lymphocytes and gingival ſ broblasts. This 
molecule is considered as involved with inƀ ammatory 
processes, matrix destruction and scarring. To the 
aforementioned, we must add the fact that there is 
a strong relationship with bone resorption process, 
which in turn suggests destructive stages of the 
condition. We can therefore state that IL-1ȕ is the 
main proinƀ ammatory cytokine produced in the gums 
and associated with periodontitis.
CONCLUSION
To conclude, we beg to state that etiological 
factors showed that in a Mexican population sample 
the number of bacteria species in the initial phase 
was greater in MCP than in G cases. In G, there was 
a reduction in species proportion of P. intermedia, 
F. nucleatum ,  A. act inomycetemcomitans .  In 
periodontitis cases there was a reduction of P. 
gingivalis, F. nucleatum, T. forsythia. This reduction 
is associated to the decrease of clinical parameters, 
as well as with IL-1ȕ reduction of concentration and 
total pg. With respect to host factors, it was conſ rmed 
that CGF volume and levels of IL-ȕ are sensitive 
markers for diagnosis and severity assessment of 
periodontal disease. This study showed that in NSPT 
response, maintenance phase is all important to 
consolidate clinical, microbiological and biochemical 
improvement of the treatment. It can be inferred that, 
the non surgical periodontal treatment had more 
impact in control periodontal disease in MCP.
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